OK
About Company
Technology
Investor Relations
Contact Us
Management
You are here: Home > About Company > Management
Senior Management Team

 

> Hugh Morgan - Chairman

> Julie Phillips - Chief Executive Officer

> Don Brooks - Non Executive Director

> Professor Larisa Rudenko - Director of Russian Projects


 

HUGH MORGAN AC - Chairman

Hugh Morgan is Principal of First Charnock; a Director of the Board of the Reserve Bank of Australia; President of the Business Council of Australia; Co-Chair of the Commonwealth Business Council; President of the Australia Japan Business Co-operation Committee and a member of the Lafarge International Advisory Board. He is also a Trustee of The Asia Society New York, Chairman of the Asia Society AustralAsia Centre; President of the National Gallery of Victoria Foundation and Chairman of the Order of Australia Association Foundation.

He is a graduate in Law and Commerce from the University of Melbourne and was Chief Executive Officer of WMC Limited from 1986 to 2003. He was a Director of Alcoa of Australia from 1977 to 1998 and a Director of Alcoa Inc from 1998 to 2001. 

 
Back To Top

JULIE PHILLIPS - Chief Executive Officer and Director 

Ms Phillips has a strong background in the biotech and pharmaceutical industries. Julie has been the CEO for a number of ASX listed biotech companies and held senior positions for multinational companies such as Sandoz and Covance. 

Additionally, she has extensive experience commercialising technologies and managing product development to international standards in Australian biotech companies. During her career she has been responsible for technology acquisition and commercialisation, fund raising, licensing and international regulatory affairs.

 
Back To Top

DON BROOKS - Non Executive Director

Don Brooks is a US based lawyer, who for many years was Senior Counsel-Licensing at Merck & Co., Inc and was formerly its Counsel for U.S. pharmaceutical operations and Counsel for its research operations.


Don retired from Merck in 1993 and since that time has served as Counsel to a U.S. law firm representing clients in the biotechnology industry, as well as serving as an advisor to firms in the biotechnology and the pharmaceutical industry in general.

He has been general counsel of a Maryland based biotech company EntreMed, Inc and currently serves on the board of that company as well as a Canadian biotech company Xenon Genetics, Inc.

 

Back To Top

Professor Larisa Rudenko - Director of Russian Projects

M.D.,PhD.,DSc

Professor Rudenko is Head of the Virology Department in the Institute of Experimental Medicine St. Petersburg, Russia.

Professor Rudenko worked with Academician Smoro dintsev and has been responsible for the clinical studies and trials of the live attenuated influenza vaccines in Russia.

She is recognised as one of the world's leading experts in the use of live attenuated influenza vaccines and as such has worked closely over the past 10 years with scientists at the Centers for Disease Control and Prevention, Atlanta, USA in developing effective influenza prophylaxis programs for use in children and in the elderly.

She has published in excess of 100 scientific papers and in 1999 her contribution to medical science was recognised with the award of the title of Honoured Scientist of the Russian Federation.

 
Back To Top

Home | |Contact|Sitemap | Privacy Policy
© BioDiem 2005